Original document(30 pages)  中文版
    The invention provides a compound orally disintegrating tablet of red sage root, its preparation method and quality control method, which is prepared from root of red rooted saliva 255g, notoginseng 50g, borneo camphor 2.85g and right amount of auxiliary materials.
Application Number
申请号		 200610200355 Application Date
申请日		 2006.04.17
Title 名称 Compound orally disintegrating tablet of red sage root, its preparation method and quality control method
Publication Number
公开号		 1827125 Publication Date
公开日		 2006.09.06
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K36/53,A61K9/20,A61P9/10,G01N30/90,G01N33/15,A61K31/045
Applicant(s) Name
申请人		 Zhejiang Dade Pharmaceutical Co., Ltd.
Address 地址 322000
Inventor(s) Name 发明人 Chen Fagui, Wang Tianxing
Attorney & Agent 代理人 guo fang
More information 更  多  信  息


 Related patents information
Azithromycin enteric casing preparation and its preparing process
Compound Astragalus mongholicus drop pellets and preparation
Iron-sheet dendrobe compound drop pellets and their preparation
Composite cottonrose hibiscus and mongolia bark drop pellets and their preparation
Composite dripping pills of 'Huoxiang Zhengqi' formulation and its preparation method
Ginkago leaf oral disintegrating tablet, and its preparing and quality control method
Azitromycin particle and method for preparing its enteric coated formulation
Effervescence tablet for treating acute bronchitis, its preparation and quality control method
Dispersible tablet with gastrodia tuber for treating headache, its preparation and quality control method
Capsule for treating gynecological diseases and preparation method and quality-control method
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.